New Jersey-based pharmaceutical company Merck & Co. says a recent study shows they have an experimental pill that reduced hospitalizations and deaths by half in people who are newly infected with COVID-19. They are planning to ask for emergency use authorization for the treatment. Dr. Angie Nicholas and Dr. Darren Mareiniss with Einstein Medical Center say the pill is a potential game changer. They join the podcast to explain what the pill does, who can benefit from taking it, and when it could be available. 

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices